| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, and assets for the years ended November 30, 2021 and November 30, 2020:
|
|
|
|
|
|
|
|
|
|
|
For the years ended November 30, |
|
|
|
2021 |
|
|
2020 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
28,397,401 |
|
|
$ |
30,176,852 |
|
PrepaCyte CB |
|
|
111,400 |
|
|
|
244,187 |
|
Public cord blood banking |
|
|
376,101 |
|
|
|
726,554 |
|
Total net revenue |
|
$ |
28,884,902 |
|
|
$ |
31,147,593 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,351,410 |
|
|
$ |
7,689,608 |
|
PrepaCyte CB |
|
|
154,140 |
|
|
|
156,111 |
|
Public cord blood banking |
|
|
1,484,186 |
|
|
|
1,811,723 |
|
Total cost of sales |
|
$ |
8,989,736 |
|
|
$ |
9,657,442 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
6,347,061 |
|
|
$ |
9,928,886 |
|
PrepaCyte CB |
|
|
(70,335 |
) |
|
|
60,499 |
|
Public cord blood banking |
|
|
(2,273,604 |
) |
|
|
(2,327,788 |
) |
Total operating profit |
|
$ |
4,003,122 |
|
|
$ |
7,661,597 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
806,230 |
|
|
$ |
138,859 |
|
PrepaCyte CB |
|
|
27,595 |
|
|
|
27,578 |
|
Public cord blood banking |
|
|
1,020 |
|
|
|
- |
|
Total depreciation and amortization |
|
$ |
834,845 |
|
|
$ |
166,437 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,378,926 |
|
|
$ |
1,544,017 |
|
PrepaCyte CB |
|
|
- |
|
|
|
- |
|
Public cord blood banking |
|
|
- |
|
|
|
- |
|
Total interest expense |
|
$ |
1,378,926 |
|
|
$ |
1,544,017 |
|
The following table shows the assets by segment as of November 30, 2021 and November 30, 2020:
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
2020 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
50,170,887 |
|
|
$ |
34,215,780 |
|
PrepaCyte CB |
|
|
250,591 |
|
|
|
302,683 |
|
Public cord blood banking |
|
|
10,240,598 |
|
|
|
11,681,631 |
|
Total assets |
|
$ |
60,662,076 |
|
|
$ |
46,200,094 |
|
|